The World Health Organization (WHO) will host the second World Local Production Forum from November 6-8, convening more than 800 attendees from more than 100 countries, including WHO member states and global health professionals, to discuss the theme, Enhancing access to medicines and other health technologies.
USP participation
Opportunities to shape market access dynamics for sustainable growth
Tuesday, November 7, 12:30 – 2pm CEST
As regional manufacturing expands, unfavorable market dynamics often prevent new and emerging manufacturers, particularly those from low- and middle-income countries, from entering the market or expanding distribution. This side session will focus on strategies that smaller, emerging manufacturers should consider when expanding operations and the components needed to make their business cases work.
Speakers
- Chimwemwe Chamdimba, African Medicines Regulation Harmonization Programme Head, African Union Development Agency (AUDA-NEPAD)
- Muhammad Rahim Uddin, Senior Regional Advisor, Asia, USP
- Ellie Marsh, Strategy, Procedure and Innovation, Supply Operations, The Global Fund
- Emmanuel Mujuru, Chairperson of Federation of African Pharmaceutical Manufacturer's Association (FAPMA)
Location: North America Room, World Forum
Addressing climate change through eco-friendly local production
Tuesday, November 7, 2:15 – 3:45pm CEST
This plenary brings together pharmaceutical experts, regulators, and other stakeholders to explore opportunities to reduce the impact that manufacturing medicines, vaccines, and other medical products has on the environment. As part of the discussion, panelists will highlight challenges and successes of eco-friendly local production and share ways to promote more sustainable manufacturing.
Speaker: Dr. Perrer Tosso, Director of Pharmaceutical Manufacturing and Supply Programs, USP
Location: Amazon Hall, World Forum
View the full agenda: https://www.who.int/publications/m/item/program-at-a-glance--second-wlpf
Not able to join? Follow us @USPGlobalHealth for updates. #WLPF #LocalProduction
Expanding capacity to produce vaccines in Africa
Read the white paper
Chimwemwe Chamdimba
Chimwemwe Chamdimba is the Head of African Medicines Regulatory Harmonization (AMRH) Initiative at the African Union Development Agency (AUDA-NEPAD). She responsible for the management of the AMRH Initiative and leading the technical support to the operationalization of the African Medicines Agency (AMA). She is leading policy reforms linking regulatory systems strengthening to procurement in support of local manufacturing of medical products and technologies. As a health policy specialist, she has spearheaded health policy and regulatory reforms, regional harmonization and partner coordination. She has contributed to key continental policies including the AU Model Law on Medical Product Regulation; the Treaty for the establishment of the African Medicines Agency (AMA); and the AU Private Sector Engagement in Health Framework.
Ellie Marsh
Ellie Marsh is Senior Manager for Strategy, Procedure and Innovation in Supply Operations at the Global Fund. She leads implementation of the NextGen Market Shaping approach focused on accelerating equitable access to quality assured health products and innovations in the fight against HIV, TB and malaria. She leads cross-Secretariat and partnership engagement to design and implement interventions aimed to accelerate product introduction and diversify the supply base and manages Global Fund’s NextGen Strategic Initiative.
Ellie joined the Global Fund at the beginning of this year from MedAccess where she was Vice President in the Health Markets Team and designed, executed and monitored market shaping interventions across HIV, TB, malaria and COVID-19, working closely with private and public sector actors. Prior to MedAccess, Ellie was a strategy consultant with Dalberg Advisors, focused on supporting a range of clients across global health. She worked extensively with international organizations, foundations, implementing partners and the private sector in Europe, South Asia and Sub-Saharan Africa to design strategies focused on improving access to health.
Originally from the UK, Ellie has a degree in Biological Natural Sciences from the University of Cambridge, and a masters in Health Economics from London School of Hygiene and Tropical Medicine.
Muhammad Rahim Uddin
Muhammad Rahim Uddin is a public health leader with specialized expertise in pharmaceutical sector strategy development, working at the intersection of government, industry, and public health to help create more resilient health systems and medical product supply chains. Currently, Mr. Uddin is the Senior Regional Advisor for Strategy at USP, working on the Promoting the Quality of Medicines Plus (PQM+) program, funded by the U.S. Agency for International Development. He provides specific technical support to aid the expansion of local production in multiple countries in Asia. His recent work includes developing local manufacturing and export strategies for Pakistan and Uzbekistan as well as conducting a landscape analysis to better understand the readiness and potential for increasing local pharmaceutical manufacturing in the Asia region.
Mr. Uddin has previously worked with the United Nations, the Gates Foundation, and other multilateral and bilateral aid agencies. His areas of expertise include private sector development, economic development, digitization, digital and financial inclusion, financial technology, workforce development, and impact evaluation. Mr. Uddin completed his Masters in Development Studies from the Institute of Development Studies at the University of Sussex and his Bachelors in Economics from the Lahore University of Management Sciences.
Emmanuel Mujuru
Emmanuel Mujuru is a pharmacist, entrepreneur, and businessman with a passion for the development of local pharmaceutical production not only in Zimbabwe but in Africa in general. He is currently a Chairperson of Federation of African Pharmaceutical Manufacturer's Association (FAPMA) and has been active in the pharmaceutical industry for the past 20 years during which he gained extensive experience in pharmaceutical production, research and development, quality assurance and marketing and distribution. Mr. Mujuru is the Chief Executive Officer and founder of Plus Five Pharmaceuticals (Pvt) Ltd a Zimbabwean-based pharmaceutical company which manufactures a wide range of generic pharmaceutical products. He is the Chairman of the Pharmaceutical Manufacturers’ Association of Zimbabwe (PMA) a national association representing pharmaceutical manufacturing companies in Zimbabwe.
Laura Herman
Laura Herman has over 20 years of global development experience working with foundations, corporations, multilaterals, and NGOs to create positive change in the world, especially across the global south. Throughout her career, she has worked to address poverty and a variety of social issues across the globe. Her career in global health has consistently prioritized health systems strengthening, fueled by a commitment to the importance of health standards, equity, quality medicines and patient education.
Herman began her consulting career as a management consultant at Deloitte in the mid-1990s, working on large scale organizational change initiatives. She joined the founding team of FSG in 2002 and led the Global Health and Gender Equity practices until 2018. During that time, she helped grow the firm to a team of 160 consultants in six offices worldwide. She then moved to Singapore to join Essilor, the world’s largest manufacturer of eyeglasses. There she was a Vice President, overseeing strategy across the company’s global inclusive business and corporate foundations. She also oversaw advocacy partnerships to advance road safety and global education objectives. Ms. Herman is currently a Principal at Dalberg Advisor’s New York office where she leads efforts to help build a more inclusive and sustainable world for everyone.
She has been a board member for VillageReach, a non-profit focused on improving “last mile” drug distribution in the global south.
Herman pursued her MBA and MA in International Policy from Stanford with the explicit intent of developing a consulting firm that would improve the effectiveness of philanthropy in the global south, starting with a focus on healthcare. She also has a BBA in International Business from the University of Michigan.